Institutional investors purchased a net $1.6 million shares of ABMD during the quarter ended December 2016 and now own 93.39% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 1.6 Million shares of Abiomed Inc
MILLENNIUM MANAGEMENT LLC Bought 440.1 Thousand shares of Abiomed Inc
RUSSELL INVESTMENT MANAGEMENT LL... Bought 282.9 Thousand shares of Abiomed Inc